|
1
|
Kontopoulou L, Vasara E, Paraskevadaki E,
Karpetas G, Papathanasiou IV and Gourgoulianis KI: Dietary
supplementation practices among undergraduate students in greece
during the COVID-19 pandemic and their association with
COVID-19-related Anxiety. Mater Sociomed. 35:140–147.
2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Silva C, Fonseca C, Ferreira R, Pinho L,
Schneider BC, Weidner A, Morgado B and Lopes MJ: Depression in
older adults during the COVID-19 pandemic: A systematic review
protocol. BMJ Open. 12(e065610)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
COVID-19 Mental Disorders Collaborators.
Global prevalence and burden of depressive and anxiety disorders in
204 countries and territories in 2020 due to the COVID-19 pandemic.
Lancet. 398:1700–1712. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kokota D, Lund C, Ahrens J, Breuer E and
Gilfillan S: Evaluation of mhGAP training for primary healthcare
workers in Mulanje, Malawi: A quasi-experimental and time series
study. Int J Ment Health Syst. 14(3)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
McCarthy J, Minsky ML, Rochester N and
Shannon CE: A Proposal for the Dartmouth Summer Research Project on
Artificial Intelligence, August 31, 1955. AI Magazine. 27:12–15.
2006.
|
|
6
|
Bi WL, Hosny A, Schabath MB, Giger ML,
Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, et
al: Artificial intelligence in cancer imaging: Clinical challenges
and applications. CA Cancer J Clin. 69:127–157. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zakhem GA, Fakhoury JW, Motosko CC and Ho
RS: Characterizing the role of dermatologists in developing
artificial intelligence for assessment of skin cancer. J Am Acad
Dermatol. 85:1544–1556. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wu W, Zhang Y, Jiang J, Lucas MV, Fonzo
GA, Rolle CE, Cooper C, Chin-Fatt C, Krepel N, Cornelssen CA, et
al: An electroencephalographic signature predicts antidepressant
response in major depression. Nat Biotechnol. 38:439–447.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nothdurfter C, Eser D, Schüle C, Zwanzger
P, Marcuse A, Noack I, Möller HJ, Rupprecht R and Baghai TC: The
influence of concomitant neuroleptic medication on safety,
tolerability and clinical effectiveness of electroconvulsive
therapy. World J Biol Psychiatry. 7:162–170. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hays R: The relevance of medical history
to current practice. Aust J Gen Pract. 53:157–160. 2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Trifu S, Sevcenco A, Stănescu M, Drăgoi AM
and Cristea MB: Efficacy of electroconvulsive therapy as a
potential first-choice treatment in treatment-resistant depression
(Review). Exp Ther Med. 22(1281)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wilkinson ST, Agbese E, Leslie DL and
Rosenheck RA: Identifying recipients of electroconvulsive therapy:
Data from privately insured americans. Psychiatr Serv. 69:542–548.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Spiric Z, Stojanovic Z, Samardzic R,
Milovanović S, Gazdag G and Marić NP: Electroconvulsive therapy
practice in Serbia today. Psychiatr Danub. 26:66–69.
2014.PubMed/NCBI
|
|
14
|
Surís A, Holliday R and North CS: The
evolution of the classification of psychiatric disorders. Behav Sci
(Basel). 6(5)2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Berlin I: The Salpetriere Hospital: from
confining the poor to freeing the insane. Am J Psychiatry.
160(1579)2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ruiz-Gomez N and Rosenstock ML: The ties
that bind past and present: Tony robert-fleury, philippe pinel and
the salpêtrière. Foren Sci Int Mind Law. 2(100049)2021.
|
|
17
|
Lehmann HE: Before they called it
psychopharmacology. Neuropsychopharmacology. 8:291–303.
1993.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Faedda GL, Becker I, Baroni A, Tondo L,
Aspland E and Koukopoulos A: The origins of electroconvulsive
therapy: Prof. Bini's first report on ECT. J Affect Disord.
120:12–15. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fink M: The origins of convulsive therapy.
Am J Psychiatry. 141:1034–1041. 1984.
|
|
20
|
Kaliora SC, Zervas IM and Papadimitriou
GN: Electroconvulsive therapy: 80 years of use in psychiatry.
Psychiatriki. 29:291–302. 2018.PubMed/NCBI View Article : Google Scholar : (In Greek,
Modern).
|
|
21
|
Fink M: Induced Seizures as Therapy in
Man. In Larry R. Squire editor. Encyclopedia of Neuroscience.
Academic Press 117-123, 2009.
|
|
22
|
Leiknes KA, Jarosh-von Schweder L and Høie
B: Contemporary use and practice of electroconvulsive therapy
worldwide. Brain Behav. 2:283–344. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
American Psychiatric Association Task
Force on Electroconvulsive Therapy: The Practice of
Electroconvulsive Therapy: Recommendations for Treatment, Training,
and Privileging. 2nd edition. American Psychiatric Association,
Washington, DC, 2001.
|
|
24
|
Dominiak M, Antosik-Wójcińska AZ, Goetz Z,
Sikorska O, Stefanowski B, Gorostiza D and Święcicki Ł: Efficacy,
safety and tolerability of formula-based unilateral vs bilateral
electroconvulsive therapy in the treatment of major depression: A
randomized open label controlled trial. J Psychiatr Res. 133:52–59.
2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Waite J and Easton A (eds): The ECT
Handbook. 3rd edition. Royal College of Psychiatrists, London,
2013.
|
|
26
|
Stojanovic Z: Evaluation
ofelectroconvulsive therapyeffects on the
cognitiveandmnesticfunctionsin patients with depression.
(unpublished PhDThesis). Faculty of Medicine, University of
Kragujevac, 2016.(In Serbian).
|
|
27
|
Joković D, Milosavljević F, Stojanović Z,
Šupić G, Vojvodić D, Uzelac B, Jukić MM and Petković Ćurčin A:
CYP2C19 slow metabolizer phenotype is associated with lower
antidepressant efficacy and tolerability. Psychiatry Res.
312(114535)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Gurel SC, Mutlu E, Başar K and Yazıcı MK:
Bi-temporal electroconvulsive therapy efficacy in bipolar and
unipolar depression: A retrospective comparison. Asian J Psychiatr.
55(102503)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Elias A, Thomas N and Sackeim HA:
Electroconvulsive Therapy in Mania: A review of 80 years of
clinical experience. Am J Psychiatry. 178:229–239. 2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sinclair DJ, Zhao S, Qi F, Nyakyoma K,
Kwong JS and Adams CE: Electroconvulsive therapy for
treatment-resistant schizophrenia. Cochrane Database Syst Rev.
3(CD011847)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Grover S, Sahoo S, Rabha A and Koirala R:
ECT in schizophrenia: A review of the evidence. Acta
Neuropsychiatr. 31:115–127. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Stojanovic Z and Spiric Z: Acute psychosis
followed by fever-Malignant Neuroleptic Syndrome or viral
encephalitis? Vojnosanit Pregl. 71:603–607. 2014.PubMed/NCBI
|
|
33
|
Morcos N, Rosinski A and Maixner DF:
Electroconvulsive therapy for neuroleptic malignant Syndrome: A
case series. J ECT. 35:225–230. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Buday J, Albrecht J, Mareš T, Podgorná G,
Horáčková K, Kališová L, Raboch J and Anders M: Brain Tumors and
electroconvulsive therapy: A literature overview of the last 80
years. Front Neurol. 11(723)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Saeedi A, Saeedi M, Maghsoudi A and
Shalbaf A: Major depressive disorder diagnosis based on effective
connectivity in EEG signals: A convolutional neural network and
long short-term memory approach. Cogn Neurodyn. 15:239–252.
2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Fitzpatrick KK, Darcy A and Vierhile M:
Delivering cognitive behavior therapy to young adults with symptoms
of depression and anxiety using a fully automated conversational
agent (Woebot): A Randomized controlled trial. JMIR Ment Health.
4(e19)2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Elvevåg B, Foltz PW, Rosenstein M and
Delisi LE: An automated method to analyze language use in patients
with schizophrenia and their first-degree relatives. J
Neurolinguistics. 23:270–284. 2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Antonucci LA, Raio A, Pergola G, Gelao B,
Papalino M, Rampino A, Andriola I, Blasi G and Bertolino A: Machine
learning-based ability to classify psychosis and early stages of
disease through parenting and attachment-related variables is
associated with social cognition. BMC Psychol. 9(47)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bain EE, Shafner L, Walling DP, Othman AA,
Chuang-Stein C, Hinkle J and Hanina A: Use of a novel artificial
intelligence platform on mobile devices to assess dosing compliance
in a phase 2 clinical trial in subjects with schizophrenia. JMIR
Mhealth Uhealth. 5(e18)2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
du Sert OP, Potvin S, Lipp O, Dellazizzo
L, Laurelli M, Breton R, Lalonde P, Phraxayavong K, O'Connor K,
Pelletier JF, et al: Virtual reality therapy for refractory
auditory verbal hallucinations in schizophrenia: A pilot clinical
trial. Schizophr Res. 197:176–181. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Pluijms EM, Kamperman AM, Hoogendijk WJ,
Birkenhäger TK and van den Broek WW: Influence of an adjuvant
antidepressant on the efficacy of electroconvulsive therapy: A
systematic review and meta-analysis. Aust N Z J Psychiatry.
55:366–380. 2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ipekcioglu D, Yazar MS, Canbek O, Yuksel
O, Meterelliyoz KS and Ilnem MC: Electroconvulsive therapy combined
with antipsychotic therapy in the treatment of acute schizophrenia
inpatients: Symptom profile of the clinical response. Psychiatry
and Clinical Psychopharmacol. 28:363–370. 2018.
|
|
43
|
Pawełczyk T, Kołodziej-Kowalska E,
Pawełczyk A and Rabe-Jabłońska J: Effectiveness and clinical
predictors of response to combined ECT and antipsychotic therapy in
patients with treatment-resistant schizophrenia and dominant
negative symptoms. Psychiatry Res. 220:175–180. 2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Patel RS, Bachu A and Youssef NA:
Combination of lithium and electroconvulsive therapy (ECT) is
associated with higher odds of delirium and cognitive problems in a
large national sample across the United States. Brain Stimul.
13:15–19. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Kellner CH, Husain MM, Knapp RG, McCall
WV, Petrides G, Rudorfer MV, Young RC, Sampson S, McClintock SM,
Mueller M, et al: A novel strategy for continuation ECT in
geriatric depression: Phase 2 of the PRIDE Study. Am J Psychiatry.
173:1110–1118. 2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Delamarre L, Galvao F, Gohier B, Poulet E
and Brunelin J: How much do benzodiazepines matter for
electroconvulsive therapy in patients with major depression? J ECT.
35:184–188. 2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zolezzi M: Medication management during
electroconvulsant therapy. Neuropsychiatr Dis Treat. 12:931–939.
2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kalisova L, Kubinova M, Michalec J,
Albrecht J, Madlova K and Raboch J: Cognitive functioning in
patients treated with electroconvulsive therapy. Neuropsychiatr Dis
Treat. 14:3025–3031. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ousdal OT, Brancati GЕ, Kessler U,
Erchinger V, Dale AM, Abbott C and Oltedal L: The neurobiological
effects of electroconvulsive therapy studied through magnetic
resonance: What Have we learned, and where do we go? Biol
Psychiatry. 91:540–549. 2022.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Jolly AJ and Singh SM: Does
electroconvulsive therapy cause brain damage: An update. Indian J
Psychiatry. 62:339–353. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Falconer DW, Cleland J, Fielding S and
Reid IC: Using the CambridgeNeuropsychological Test Automated
Battery (CANTAB) to assess the cognitive impact ofelectroconvulsive
therapy on visual and visuospatial memory. Psychol Med.
40:1017–1025. 2010.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Fernie G, Bennett DM, Currie J, Perrin JS
and Reid IC: Detecting objective and subjective cognitive effects
of electroconvulsive therapy: Intensity, duration and test utility
in a large clinical sample. Psychol Med. 44:2985–2994.
2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Kalogerakou S, Oulis P, Anyfandi E,
Konstantakopoulos G, Papakosta VM, Kontis D, Theochari E,
Angelopoulos E, Zervas IM, Mellon RC, et al: Episodic Visual
learning/memory and attentional flexibility in patients with major
depressive disorder after clinically effective electroconvulsive
therapy. J ECT. 31:246–252. 2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Maric NP, Stojanovic Z, Andric S,
Soldatovic I, Dolic M and Spiric Z: The acute and medium-term
effects of treatment with electroconvulsive therapy on memory in
patients with major depressive disorder. Psychol Med. 46:797–806.
2016.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Stojanovic Z, Andric S, Soldatovic I,
Dolic M, Spiric Z and Maric NP: Executive function in
treatment-resistant depression before and after electroconvulsive
therapy. World J Biol Psychiatry. 18:624–632. 2017.PubMed/NCBI View Article : Google Scholar
|
|
56
|
van Buel EM, Sigrist H, Seifritz E, Fikse
L, Bosker FJ, Schoevers RA, Klein HC, Pryce CR and Eisel UL: Mouse
repeated electroconvulsive seizure (ECS) does not reverse social
stress effects but does induce behavioral and hippocampal changes
relevant to electroconvulsive therapy (ECT) side-effects in the
treatment of depression. PLoS One. 12(e0184603)2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Maffioletti E, Carvalho Silva R,
Bortolomasi M, Baune BT, Gennarelli M and Minelli A: Molecular
biomarkers of electroconvulsive therapy effects and clinical
response: Understanding the present to shape the future. Brain Sci.
11(1120)2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Singh A and Kar SK: How Electroconvulsive
Therapy Works?: Understanding the neurobiological mechanisms. Clin
Psychopharmacol Neurosci. 15:210–221. 2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
An X and Wang Y: Electroconvulsive shock
increases neurotrophy and neurogenesis: Time course and treatment
session effects. Psychiatry Res. 309(114390)2022.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Polyakova M, Schroeter ML, Elzinga BM,
Holiga S, Schoenknecht P, de Kloet ER and Molendijk ML:
Brain-Derived neurotrophic factor and antidepressive effect of
electroconvulsive therapy: Systematic review and meta-analyses of
the preclinical and clinical literature. PLoS One.
10(e0141564)2015.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Chen F, Danladi J, Wegener G, Madsen TM
and Nyengaard JR: sustained ultrastructural changes in rat
hippocampal formation after repeated electroconvulsive seizures.
Int J Neuropsychopharmacol. 23:446–458. 2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Conti G, Gale K and Kondratiev A:
Immunohistochemical evaluation of the protein ekpression of nerve
grovth factor and its TrkA receptor in rat limbic regions after
electroshock seizures. Neurosci Res. 65:201–209. 2009.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Kim J, Gale K and Kondratyev A: Effects of
repeated minimal electroshock seizures on NGF, BDNF and FGF-2
protein in the rat brain during postnatal development. Int J Dev
Neurosci. 28:227–232. 2010.PubMed/NCBI View Article : Google Scholar
|
|
64
|
van Zutphen EM, Rhebergen D, van Exel E,
Oudega ML, Bouckaert F, Sienaert P, Vandenbulcke M, Stek M and Dols
A: Brain-derived neurotrophic factor as a possible predictor of
electroconvulsive therapy outcome. Transl Psychiatry.
9(155)2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Zhang T, Tang X, Wei Y, Xu L, Hu Y, Cui H,
Zeng J, Ye J, Xie Y, Tang Y, et al: Serum angioneurin levels
following electroconvulsive therapy for mood disorders. Bipolar
Disord. 25:671–682. 2023.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Pacitti F, Bersani G, Aloe L, Caredda M,
Orsi P, Quartini A, Vitali M, Ceccanti M, Tirassa P, Fiore M and
Iannitelli A: Nerve growth factor serum levels in
treatment-resistant schizophrenic patients following
electroconvulsive therapy. Clin Ter. 171:e67–e74. 2021.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Iannitelli A, Aloe L, Fiore M and Bersani
G: Changes in Nerve Growth Factor plasma levels during
Electroconvulsive Therapy-Variazioni nei livelli plasmatici del
nerve growth factor in risposta alla terapia elettroconvulsivante.
Giornale Italiano di Psicopatologia. 7:275–282. 2001.(In
Italian).
|
|
68
|
Kato M, Okugawa G, Wakeno M, Takekita Y,
Nonen S, Tetsuo S, Nishida K, Azuma J, Kinoshita T and Serretti A:
Effect of basic fibroblast growth factor (FGF2) gene polymorphisms
on SSRIs treatment response and side effects. Eur
Neuropsychopharmacol. 19:718–725. 2009.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Deng Y, Li W and Zhang B: Functional
Activity in the Effect of Transcranial Magnetic Stimulation Therapy
for Patients with Depression: A Meta-Analysis. J Pers Med.
13(405)2023.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Křenek P, Hořínková J and Bartečků E:
Peripheral inflammatory markers in subtypes and core features of
depression: A systematized review. Psychopathology. 56:403–416.
2023.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Foley ÉM, Parkinson JT, Kappelmann N and
Khandaker GM: Clinical phenotypes of depressed patients with
evidence of inflammation and somatic symptoms. Compr
Psychoneuroendocrinol. 8(100079)2021.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Lee CH and Giuliani F: The role of
inflammation in depression and fatigue. Front Immunol.
10(1696)2019.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Yrondi A, Sporer M, Péran P, Schmitt L,
Arbus C and Sauvaget A: Electroconvulsive therapy, depression, the
immune system and inflammation: A systematic review. Brain Stimul.
11:29–51. 2018.PubMed/NCBI View Article : Google Scholar
|
